Publication:
The first case of autosomal recessive cerebellar ataxia with prominent paroxysmal non-kinesigenic dyskinesia caused by a truncating FGF14 variant in a Turkish patient

dc.contributor.coauthorTürkdoğan D., Yeşilyurt A., Houlden H., Zuchner S., Brais B., Pellerin D.
dc.contributor.departmentKUTTAM (Koç University Research Center for Translational Medicine)
dc.contributor.departmentNDAL (Neurodegeneration Research Laboratory)
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorSmolina, Natalia
dc.contributor.kuauthorTekgül, Şeyma
dc.contributor.kuauthorGül, Tuğçe
dc.contributor.kuauthorBaşak, Ayşe Nazlı
dc.contributor.schoolcollegeinstituteLaboratory
dc.contributor.schoolcollegeinstituteResearch Center
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2025-03-06T20:59:31Z
dc.date.issued2024
dc.description.abstractBackground: ATX-FGF/SCA27A has been exclusively associated with heterozygous variants in the FGF14 gene, presenting with postural tremor, slowly progressive cerebellar ataxia, and psychiatric and behavioral disturbances. Objectives: This study describes the first case of ATX-FGF/SCA27A linked to a biallelic frameshift variant in the FGF14 gene. Methods: Whole-exome sequencing (WES) was conducted using the Illumina NovaSeq 6000 platform, and the identified variant was confirmed using Sanger sequencing. Results: We report the first case of autosomal recessive FGF14-related cerebellar ataxia caused by a c.75del variant resulting in p.Leu26Serfs*51 truncation of the FGF14 protein. This variant was found in a patient born to consanguineous parents and presented with a complex congenital nonprogressive cerebellar disorder accompanied by neurodevelopmental delay, intellectual disability, and prominent drug-responsive paroxysmal non-kinesigenic dyskinesia. Segregation analysis confirmed that the homozygous variant was inherited from heterozygous parents who developed mild gait ataxia and tremor in their 40s. Conclusions: Biallelic loss-of-function variants in FGF14 are a rare cause of inherited cerebellar ataxia and expand the current genetic spectrum of ATX-FGF14.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuEU
dc.description.sponsorshipThis work was supported by Suna and \u0130nan K\u0131ra\u00E7 Foundation Research Funds (2022\u20132024) and Ko\u00E7 University funds. D.P. holds a Fellowship award from the Canadian Institutes of Health Research. B.B. is supported by the Canadian Institutes of Health Research (grant 189963) and the Fondation Groupe Monaco. S.Z. is supported by the NIH National Institutes of Neurological Disorders and Stroke (grant 2R01NS072248\u201011A1). H.H. is supported by the Wellcome Trust, the UK Medical Research Council (MRC), and the UCLH/UCL Biomedical Research Centre. Funding agencies:
dc.identifier.doi10.1002/mds.30087
dc.identifier.grantnoMedical Research Council, MRC; Koç Üniversitesi, KU; UCLH Biomedical Research Centre, NIHR BRC; Wellcome Trust, WT; Koç Üniversitesi Translasyonel Tıp Araştırma Merkezi, KUTTAM; University College London, UCL; Fondation Groupe Monaco; Suna ve İnan Kıraç Vakfı, SVİKV: 2022–2024; Suna ve İnan Kıraç Vakfı, SVİKV; Canadian Institutes of Health Research, CIHR: 189963; Canadian Institutes of Health Research, CIHR; National Institute of Neurological Disorders and Stroke, NINDS: 2R01NS072248‐11A1; National Institute of Neurological Disorders and Stroke, NINDS
dc.identifier.issn0885-3185
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85212516051
dc.identifier.urihttps://doi.org/10.1002/mds.30087
dc.identifier.urihttps://hdl.handle.net/20.500.14288/27728
dc.identifier.wos1380343900001
dc.keywordsAtaxia
dc.keywordsFGF14
dc.keywordsSCA27A
dc.language.isoeng
dc.publisherJohn Wiley and Sons Inc
dc.relation.ispartofMovement Disorders
dc.subjectBiochemistry and molecular biology
dc.titleThe first case of autosomal recessive cerebellar ataxia with prominent paroxysmal non-kinesigenic dyskinesia caused by a truncating FGF14 variant in a Turkish patient
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorSmolina, Natalia
local.contributor.kuauthorTekgül, Şeyma
local.contributor.kuauthorGül, Tuğçe
local.contributor.kuauthorBaşak, Ayşe Nazlı
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit1Research Center
local.publication.orgunit1Laboratory
local.publication.orgunit2KUTTAM (Koç University Research Center for Translational Medicine)
local.publication.orgunit2NDAL (Neurodegeneration Research Laboratory)
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublication91bbe15d-017f-446b-b102-ce755523d939
relation.isOrgUnitOfPublicationd6cdc646-db27-4078-a933-2db6f139bb65
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscovery91bbe15d-017f-446b-b102-ce755523d939
relation.isParentOrgUnitOfPublication20385dee-35e7-484b-8da6-ddcc08271d96
relation.isParentOrgUnitOfPublicationd437580f-9309-4ecb-864a-4af58309d287
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery20385dee-35e7-484b-8da6-ddcc08271d96

Files